Patel Sanjiv

President and CEO, DirectorRelay Therapeutics, Inc. (RLAY) · full profile →Form 4 · filed Jul 10, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$219K
Net Open-Market Flow
-$219K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 9, 2025Sell(S)19K$3.57$67K765K
Jul 9, 2025Sell(S)43K$3.57$153K784K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-095093) within minutes of acceptance. Every field above traces to the original document. Verify it directly: